T cell migration and effector function differences in familial adenomatous polyposis patients with
APC
Adenomatous polyposis coli
T cell activation
T cell migration
cytokines
cytoskeleton
familial adenomatous polyposis
immunological synapse
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
02
2023
accepted:
11
05
2023
medline:
4
8
2023
pubmed:
3
8
2023
entrez:
3
8
2023
Statut:
epublish
Résumé
Familial adenomatous polyposis (FAP) is an inherited disease characterized by the development of large number of colorectal adenomas with high risk of evolving into colorectal tumors. Mutations of the
Identifiants
pubmed: 37533857
doi: 10.3389/fimmu.2023.1163466
pmc: PMC10393261
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1163466Informations de copyright
Copyright © 2023 Cuche, Mastrogiovanni, Juzans, Laude, Ungeheuer, Krentzel, Gariboldi, Scott-Algara, Madec, Goyard, Floch, Chauveau-Le Friec, Lafaye, Renaudat, Le Bidan, Micallef, Schmutz, Mella, Novault, Hasan, Duffy, Di Bartolo and Alcover.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6585-E6594
pubmed: 28716933
Adv Exp Med Biol. 2009;656:30-40
pubmed: 19928350
Front Cell Dev Biol. 2020 Oct 21;8:591348
pubmed: 33195256
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):E4482-91
pubmed: 24194549
Hum Mutat. 2014 May;35(5):532-6
pubmed: 24599579
Immunity. 2015 May 19;42(5):864-76
pubmed: 25992860
Immunity. 2014 Mar 20;40(3):436-50
pubmed: 24656047
J Cell Sci. 2013 Feb 15;126(Pt 4):873-7
pubmed: 23589686
Exp Hematol. 2004 Aug;32(8):748-55
pubmed: 15308326
Curr Opin Immunol. 2021 Oct;72:21-26
pubmed: 33756276
Front Oncol. 2022 Apr 07;12:868164
pubmed: 35463357
Cell Rep. 2017 Oct 3;21(1):181-194
pubmed: 28978472
J Cell Biol. 2013 Feb 4;200(3):249-58
pubmed: 23382461
Dev Cell. 2004 Dec;7(6):871-83
pubmed: 15572129
Cancer Cell. 2005 Sep;8(3):211-26
pubmed: 16169466
J Control Release. 2016 Dec 10;243:1-10
pubmed: 27671875
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
J Immunol. 1999 Dec 1;163(11):5954-63
pubmed: 10570282
Mol Cancer Res. 2019 Sep;17(9):1828-1841
pubmed: 31160382
Front Oncol. 2018 Aug 21;8:322
pubmed: 30186768
Adv Anat Embryol Cell Biol. 2016;219:69-93
pubmed: 27207363
Cancer Res. 2009 Jul 1;69(13):5490-7
pubmed: 19570783
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Appl Clin Genet. 2015 Apr 16;8:95-107
pubmed: 25931827
Biomed J. 2022 Apr;45(2):299-309
pubmed: 34626864
Front Cell Neurosci. 2017 Aug 08;11:235
pubmed: 28848398
Cell. 2020 Apr 2;181(1):46-62
pubmed: 32243795
Curr Opin Immunol. 2023 Feb;80:102283
pubmed: 36709596
Biochimie. 2019 Feb;157:64-71
pubmed: 30414835
Cell. 2014 Jul 17;158(2):368-382
pubmed: 25036633
Clin Exp Immunol. 2010 Sep;161(3):471-9
pubmed: 20636398
Cells. 2020 Sep 19;9(9):
pubmed: 32961708
Allergy. 2020 Nov;75(11):2952-2956
pubmed: 32407549
Eur J Cancer. 2002 May;38(7):867-71
pubmed: 11978510
Nat Rev Immunol. 2002 May;2(5):309-22
pubmed: 12033737
Sci Adv. 2022 Apr 15;8(15):eabl5942
pubmed: 35417240
J Cell Biol. 2010 Jun 28;189(7):1087-96
pubmed: 20566685
Trends Cancer. 2020 Jul;6(7):605-618
pubmed: 32610070
Immunohorizons. 2020 Jun 24;4(6):363-381
pubmed: 32581014
Adv Immunol. 2005;88:1-50
pubmed: 16227086
Cell. 2016 Oct 6;167(2):397-404.e9
pubmed: 27667683